Laurent Pharmaceuticals
Laurent Pharmaceuticals is a private orphan drug company developing a first-in-class oral therapy with potential to modulate the immuno-inflammatory response in cystic fibrosis patients. Laurent has a clinical stage drug development program (LAU-7b) addre
Laurent Pharmaceuticals, private company, rare diseases, cystic fibrosis, respiratory, small molecule, first-in-class, disease-modifying, inflammation, infection, Pseudomonas aeruginosa, clinical, Phase 1b
Is this your site? Certify your site and update informations
